Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $809.02 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $470.00 | 4 | $0 (2023) |
| Covidien LP | $124.06 | 1 | $0 (2019) |
| Endogastric Solutions, Inc | $116.31 | 1 | $0 (2019) |
| Kaleo, Inc. | $46.15 | 1 | $0 (2019) |
| TerSera Therapeutics LLC | $37.15 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $15.35 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.50 | 2 | TerSera Therapeutics LLC ($37.15) |
| 2023 | $120.00 | 1 | Gilead Sciences, Inc. ($120.00) |
| 2022 | $100.00 | 1 | Gilead Sciences, Inc. ($100.00) |
| 2020 | $125.00 | 1 | Gilead Sciences, Inc. ($125.00) |
| 2019 | $411.52 | 4 | Gilead Sciences, Inc. ($125.00) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Oncology | ||||||
| 03/20/2024 | TerSera Therapeutics LLC | Quzyttir (Drug) | Food and Beverage | In-kind items and services | $37.15 | General |
| Category: Acute Care | ||||||
| 02/24/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: HBV | ||||||
| 01/14/2022 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: HBV | ||||||
| 03/06/2020 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 04/07/2019 | Kaleo, Inc. | EVZIO (Drug) | Food and Beverage | In-kind items and services | $46.15 | General |
| Category: OPIOID ANTAGONIST | ||||||
| 03/05/2019 | Covidien LP | Bravo (Device) | Food and Beverage | In-kind items and services | $124.06 | General |
| Category: Ablation | ||||||
| 02/28/2019 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $116.31 | General |
| Category: GERD | ||||||
| 01/18/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 61 | $10,675 | $6,205 |
| 2022 | 2 | 30 | 95 | $14,450 | $7,835 |
| 2021 | 3 | 41 | 113 | $13,605 | $8,961 |
| 2020 | 2 | 29 | 77 | $8,910 | $5,045 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 61 | $10,675 | $6,205 | 58.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 80 | $14,000 | $7,791 | 55.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 15 | $450.00 | $44.49 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 70 | $10,290 | $6,861 | 66.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 26 | $2,805 | $2,050 | 73.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 17 | $510.00 | $51.00 | 10.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 60 | $8,400 | $4,994 | 59.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 11 | 17 | $510.00 | $50.94 | 10.0% |
About Dr. Bao Le, MD
Dr. Bao Le, MD is a General Practice healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821027418.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bao Le, MD has received a total of $809.02 in payments from pharmaceutical and medical device companies, with $52.50 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($809.02).
As a Medicare-enrolled provider, Le has provided services to 115 Medicare beneficiaries, totaling 346 services with total Medicare billing of $28,046. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Long Beach, CA
- Active Since 07/03/2006
- Last Updated 07/21/2010
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1821027418
Products in Payments
- Vemlidy (Drug) $470.00
- Bravo (Device) $124.06
- ESOPHYX (Device) $116.31
- EVZIO (Drug) $46.15
- Quzyttir (Drug) $37.15
- ENHERTU (Biological) $15.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Long Beach
Dr. Robert Campbell, D.d.s, D.D.S
General Practice — Payments: $610,386
Dr. Michael Jensen, D.d.s, D.D.S
General Practice — Payments: $17,472
Dr. Marc Lapinel, Dds, DDS
General Practice — Payments: $8,283
Jeffrey Cohen, D.d.s, D.D.S
General Practice — Payments: $6,571
Dr. Atef Boutros, Dds, DDS
General Practice — Payments: $6,405
Dr. Henrico Mungcal, M.d, M.D
General Practice — Payments: $4,644